Want to contact a Washington, DC Singulair attorney? ...Get a free case evaluation from one of our Washington, DC Singulair attorneys now.
Home : Unsafe Drugs : Singulair : News Articles
Singulair - News Articles
-
Aug 1, 2008
International Herald Tribune, France -
Inc.'s Singulair tablets. Some analysts have speculated that FDA has become more cautious about putting new drugs on the market following the safety concerns around drugs like Merck's painkiller Vioxx and GlaxoSmithKline's diabetes drug Avandia. In both cases, there were older medications ... -
Jul 11, 2008
Chicago Tribune, United States -
Advisers to the US Food and Drug Administration on Thursday opposed a stepped-up warning about suicide risks from epilepsy drugs, including Abbott ... -
Jul 11, 2008
Wall Street Journal Blogs, NY -
Until yesterday, the FDA had been rolling steadily toward slapping a black-box warning on epilepsy drugs because they may increase the risk of suicidal thoughts and behaviors. But a committee of outside experts convened by the FDA thinks that’s a bad idea. ... -
Jul 11, 2008
Wall Street Journal Blogs, NY -
By Jared A. Favole BELTSVILLE, Md. -- A Food and Drug Administration panel has recommended against adding the agency's toughest warnings to labels of epilepsy drugs, saying studies didn't show a high-enough risk for suicidal behavior to warrant such warnings. ... -
Jul 11, 2008
Wired News -
By Brandon Keim July 11, 2008 | 10:43:42 AMCategories: Drugs & Alcohol, Government An FDA advisory panel has recommended against putting "black box" warnings on epilepsy drugs linked to a small increased risk of suicide . Though the panel's 14-4 vote ... -
Jul 11, 2008
Motley Fool -
By Brian Orelli July 11, 2008 Comments (0) When Pfizer's (NYSE: PFE) epilepsy drug Lyrica was included in a list of 11 drugs that might need a black-box warning, company executives said it wasn't so. They argued that Lyrica is different and doesn't deserve a warning. In ... -
Jul 22, 2008
Trading Markets (press release), CA -
LONDON, Jul 22, 2008 (Thomson Financial via COMTEX) -- JMPLY | Quote | Chart | News | PowerRating -- Shares in Johnson Matthey Plc. were higher in midmorning deals after a trading statement from the UK specialty chemicals and precious metals group, with Merrill Lynch keeping ... -
Jul 22, 2008
Trading Markets (press release), CA -
NEW YORK, Jul 22, 2008 (Thomson Financial via COMTEX) -- MRK | Quote | Chart | News | PowerRating -- Shares of Merck & Co. sank Tuesday after the company ... -
Jul 22, 2008
Seeking Alpha, NY -
up with Merck after the company withheld its year-end earnings guidance and trimmed projected sales for two of its core drugs, Gardasil and Singulair. The news led to a smattering of analyst downgrades, and with that in mind we see Merck shares down ... -
Jul 22, 2008
Motley Fool -
By Brian Orelli July 22, 2008 Comments (0) Investors should have expected bad news yesterday, after Merck (NYSE: MRK) and Schering-Plough (NYSE: SGP) ...
-
Jul 22, 2008
Reuters -
By Ransdell Pierson - Analysis NEW YORK (Reuters) - The glory is quickly fading for drugmaker Merck & Co, which dazzled investors over the past three years by recovering from a crisis over its Vioxx painkiller and rolling out blockbuster products. ... -
Jul 23, 2008
Forbes, NY -
AP 07.23.08, 4:29 PM ET Vytorin partners Merck & Co. and Schering-Plough Corp. have prepared a letter for physicians who might be concerned over recent study results that showed patients taking the cholesterol drug were at higher risk of dying from cancer. ... -
Jul 23, 2008
Reuters -
WASHINGTON (Reuters) - Cancer findings in a new study of cholesterol drug Vytorin are "likely to be an anomaly" unrelated to the drug, makers Merck & Co (MRK.N: Quote , Profile , Research ) and Schering-Plough Corp (SGP.N: Quote , Profile ... -
Jul 24, 2008
USA Today -
By Steve Sternberg, USA TODAY A study that unexpectedly linked the heart drug Vytorin to excess cancer deaths has provoked controversy among heart specialists worried that the drug's risks may outweigh its benefits. The study, called SEAS, was designed to ... -
Friday, August 08, 2008
Nashville City Paper, TN -
“This calls for a Singulair.” I patted my purse, smiling in anticipatory delight as I heard the comforting rattle of the pill bottle inside. In response, the moms giggled. “Oh Lindsay,” one of them said, shaking her head. “You’re such a kidder.” ... -
Aug 4, 2008
Kurier, Austria -
Als Alternative zum Kortison gibt es ua eine Substanz (Montelukast), die die Aktivität bestimmter Entzündungsstoffe (Leukotriene) hemmt. ... -
Jul 8, 2008
Herald.ie, Ireland -
Other prescribed medication that can help includes the leukotriene receptor antagonists such as Singulair, taken regularly. Corticosteroids are another option, generally used for severe cases. Alternatively, Quercetin is a bioflavonoid that has ... -
Tuesday, August 05, 2008
CNNMoney.com -
s (MRK) allergy and asthma drug Singulair is the most prescribed product in the US respiratory market, and last year it cracked the list of the Top 10 ... -
Aug 2, 2008
Peninsula On-line, Qatar -
WASHINGTON • The unusual rejection of an experimental drug that had unanimous support from outside experts signals further caution by the US Food and Drug Administration and increased uncertainty for investors. ... -
Aug 3, 2008
Therapeutics Daily (subscription) (press release), PA -
Schering shares dip after drug's rejection center BRIEFLY Shares of Schering-Plough fell 3 percent yesterday after regulators rejected the drugmaker's ...
Want to contact a Washington, DC Singulair attorney? ...Get a free case evaluation from one of our Washington, DC Singulair attorneys now.
Pages: Previous 1 2 3 4 5 6 7 ... Next
